Institutional & Family Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $5.16M | Buy |
35,297
+996
| +3% | +$148K | 0.79% | 29 |
|
|
2024
Q1 | $5.43M | Sell |
34,301
-491
| -1% | -$78.2K | 0.86% | 23 |
|
|
2023
Q4 | $5.45M | Buy |
34,792
+335
| +1% | +$51.4K | 0.9% | 22 |
|
|
2023
Q3 | $5.37M | Buy |
34,457
+99
| +0.3% | +$16.3K | 0.88% | 27 |
|
|
2023
Q2 | $5.69M | Buy |
34,358
+93
| +0.3% | +$15K | 0.92% | 24 |
|
|
2023
Q1 | $5.31M | Buy |
34,265
+1,136
| +3% | +$183K | 0.88% | 29 |
|
|
2022
Q4 | $5.85M | Buy |
33,129
+162
| +0.5% | +$28K | 0.97% | 18 |
|
|
2022
Q3 | $5.38M | Buy |
32,967
+453
| +1% | +$76.7K | 0.95% | 19 |
|
|
2022
Q2 | $5.77M | Buy |
32,514
+721
| +2% | +$128K | 0.99% | 18 |
|
|
2022
Q1 | $5.63M | Buy |
31,793
+318
| +1% | +$54.1K | 0.88% | 19 |
|
|
2021
Q4 | $5.38M | Sell |
31,475
-628
| -2% | -$103K | 0.84% | 19 |
|
|
2021
Q3 | $5.18M | Sell |
32,103
-64
| -0.2% | -$10.9K | 0.83% | 18 |
|
|
2021
Q2 | $5.3M | Buy |
32,167
+3,715
| +13% | +$615K | 0.87% | 18 |
|
|
2021
Q1 | $4.68M | Buy |
28,452
+459
| +2% | +$74.3K | 0.91% | 17 |
|
|
2020
Q4 | $4.41M | Sell |
27,993
-181
| -0.6% | -$26.7K | 0.93% | 18 |
|
|
2020
Q3 | $4.2M | Sell |
28,174
-2,098
| -7% | -$310K | 0.98% | 16 |
|
|
2020
Q2 | $4.26M | Sell |
30,272
-1,301
| -4% | -$190K | 0.88% | 19 |
|
|
2020
Q1 | $4.14M | Buy |
31,573
+572
| +2% | +$81.2K | 0.95% | 18 |
|
|
2019
Q4 | $4.52M | Sell |
31,001
-636
| -2% | -$86.3K | 0.96% | 20 |
|
|
2019
Q3 | $4.09M | Sell |
31,637
-3,629
| -10% | -$478K | 0.9% | 27 |
|
|
2019
Q2 | $4.91M | Sell |
35,266
-573
| -2% | -$79.3K | 1.06% | 18 |
|
|
2019
Q1 | $5.01M | Sell |
35,839
-280
| -0.8% | -$37.5K | 1.05% | 18 |
|
|
2018
Q4 | $4.66M | Sell |
36,119
-3,818
| -10% | -$533K | 1.05% | 18 |
|
|
2018
Q3 | $5.52M | Buy |
39,937
+3,433
| +9% | +$456K | 1.09% | 16 |
|
|
2018
Q2 | $4.43M | Buy |
36,504
+1,757
| +5% | +$219K | 0.92% | 21 |
|
|
2018
Q1 | $4.45M | Sell |
34,747
-3,093
| -8% | -$418K | 0.94% | 20 |
|
|
2017
Q4 | $5.29M | Buy |
37,840
+5,429
| +17% | +$756K | 1.01% | 18 |
|
|
2017
Q3 | $4.21M | Buy |
32,411
+1,502
| +5% | +$199K | 0.85% | 31 |
|
|
2017
Q2 | $4.09M | Sell |
30,909
-1,638
| -5% | -$209K | 1% | 24 |
|
|
2017
Q1 | $4.05M | Sell |
32,547
-365
| -1% | -$43.6K | 1.26% | 18 |
|
|
2016
Q4 | $3.79M | Buy |
32,912
+205
| +0.6% | +$23.7K | 1.2% | 34 |
|
|
2016
Q3 | $3.86M | Buy |
32,707
+2,101
| +7% | +$255K | 1.29% | 19 |
|
|
2016
Q2 | $3.71M | Buy |
30,606
+577
| +2% | +$65.6K | 1.29% | 14 |
|
|
2016
Q1 | $3.08M | Buy |
30,029
+640
| +2% | +$66.3K | 1.15% | 21 |
|
|
2015
Q4 | $3.02M | Buy |
+29,389
| New | +$2.96M | 1.13% | 22 |
|
Other funds holding JNJ
Institutional & Family Asset Management's JNJ Position: Q2 2024 in Review
Institutional & Family Asset Management increased its Johnson & Johnson (JNJ) stake by 2.9% in Q2 2024, buying an estimated $148K and bringing the position to 35,297 shares worth $5.16M. The position accounts for 0.79% of the portfolio, ranked #29.
Institutional & Family Asset Management first reported a position in JNJ in Q4 2015 and has held it in 35 quarters since. The position peaked at $5.85M in Q4 2022. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.
- Institutional & Family Asset Management held 35,297 shares of Johnson & Johnson worth $5.16M as of Q2 2024.
- Institutional & Family Asset Management bought 996 Johnson & Johnson shares in Q2 2024, an estimated $148K.
- Johnson & Johnson made up 0.79% of Institutional & Family Asset Management's portfolio in Q2 2024, its #29 holding.
- Institutional & Family Asset Management first reported a position in Johnson & Johnson in Q4 2015 and has held it in 35 quarters since.
- Institutional & Family Asset Management's Johnson & Johnson position peaked at $5.85M in Q4 2022.
- 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.
Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.